{"id":"https://openalex.org/W4392235441","doi":"https://doi.org/10.1111/dom.15461","title":"Renal outcomes with sodium\u2010glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases","display_name":"Renal outcomes with sodium\u2010glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases","publication_year":2024,"publication_date":"2024-02-27","ids":{"openalex":"https://openalex.org/W4392235441","doi":"https://doi.org/10.1111/dom.15461","pmid":"https://pubmed.ncbi.nlm.nih.gov/38413384"},"language":"en","primary_location":{"id":"doi:10.1111/dom.15461","doi":"https://doi.org/10.1111/dom.15461","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.15461","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15461","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15461","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080530287","display_name":"Hiroaki Iijima","orcid":"https://orcid.org/0000-0003-4621-2394","observed_orcids":["https://orcid.org/0000-0003-4621-2394"]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroaki Iijima","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation  Tokyo Japan"],"raw_orcid":"https://orcid.org/0000-0003-4621-2394","affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation  Tokyo Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Maki Gouda","orcid":"https://orcid.org/0000-0003-2722-5202","observed_orcids":["https://orcid.org/0000-0003-2722-5202"]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Maki Gouda","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation  Tokyo Japan"],"raw_orcid":"https://orcid.org/0000-0003-2722-5202","affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation  Tokyo Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059505720","display_name":"Hideaki Hida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideaki Hida","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation  Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation  Tokyo Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083876246","display_name":"Kazumi Mori\u2010Anai","orcid":"https://orcid.org/0000-0002-7353-4201","observed_orcids":["https://orcid.org/0000-0002-7353-4201"]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kazumi Mori\u2010Anai","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation  Tokyo Japan"],"raw_orcid":"https://orcid.org/0000-0002-7353-4201","affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation  Tokyo Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101831167","display_name":"Akiko Takahashi","orcid":"https://orcid.org/0009-0006-4275-4654","observed_orcids":["https://orcid.org/0009-0006-4275-4654"]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akiko Takahashi","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation  Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation  Tokyo Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094020318","display_name":"Ryoichi Minai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryoichi Minai","raw_affiliation_strings":["Datack, Inc.  Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Datack, Inc.  Tokyo Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113563649","display_name":"Hideki Ninomiya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hideki Ninomiya","raw_affiliation_strings":["Datack, Inc.  Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Datack, Inc.  Tokyo Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088025850","display_name":"Yoshiyuki Saito","orcid":"https://orcid.org/0000-0002-8226-9219","observed_orcids":["https://orcid.org/0000-0002-8226-9219"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshiyuki Saito","raw_affiliation_strings":["Datack, Inc.  Tokyo Japan"],"raw_orcid":"https://orcid.org/0000-0002-8226-9219","affiliations":[{"raw_affiliation_string":"Datack, Inc.  Tokyo Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012190291","display_name":"Atsushi Miyawaki","orcid":"https://orcid.org/0000-0001-6126-1464","observed_orcids":["https://orcid.org/0000-0001-6126-1464"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atsushi Miyawaki","raw_affiliation_strings":["Datack, Inc.  Tokyo Japan","Department of Health Services Research, Graduate School of Medicine The University of Tokyo  Tokyo Japan","Department of Public Health, Graduate School of Medicine The University of Tokyo  Tokyo Japan"],"raw_orcid":"https://orcid.org/0000-0001-6126-1464","affiliations":[{"raw_affiliation_string":"Datack, Inc.  Tokyo Japan","institution_ids":[]},{"raw_affiliation_string":"Department of Health Services Research, Graduate School of Medicine The University of Tokyo  Tokyo Japan","institution_ids":["https://openalex.org/I74801974"]},{"raw_affiliation_string":"Department of Public Health, Graduate School of Medicine The University of Tokyo  Tokyo Japan","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007276836","display_name":"Jun Wada","orcid":"https://orcid.org/0000-0003-1468-5170","observed_orcids":["https://orcid.org/0000-0003-1468-5170"]},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jun Wada","raw_affiliation_strings":["Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Faculty of Medicine, Dentistry and Pharmaceutical Sciences Okayama University  Okayama Japan"],"raw_orcid":"https://orcid.org/0000-0003-1468-5170","affiliations":[{"raw_affiliation_string":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Faculty of Medicine, Dentistry and Pharmaceutical Sciences Okayama University  Okayama Japan","institution_ids":["https://openalex.org/I163770644"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5083876246"],"corresponding_institution_ids":["https://openalex.org/I4387155982"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":1.3093,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.78783098,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":96},"biblio":{"volume":"26","issue":"5","first_page":"1615","last_page":"1623"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7583000063896179,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7583000063896179,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.23109999299049377,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9760000109672546},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8009999990463257},{"id":"https://openalex.org/keywords/renal-outcomes","display_name":"renal outcomes","score":0.7960000038146973},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.9259999990463257},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate-decline","display_name":"estimated glomerular filtration rate decline","score":0.9190000295639038},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.9380000233650208},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.7940000295639038},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.878000020980835}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.917741060256958},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.66705322265625},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6130589842796326},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5995801687240601},{"id":"https://openalex.org/C537181965","wikidata":"https://www.wikidata.org/wiki/Q658","display_name":"Sodium","level":2,"score":0.5439292788505554},{"id":"https://openalex.org/C188053792","wikidata":"https://www.wikidata.org/wiki/Q3640664","display_name":"Cotransporter","level":3,"score":0.5400517582893372},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5207857489585876},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4037597179412842},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.40166306495666504},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000095225","descriptor_name":"East Asian People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.15461","doi":"https://doi.org/10.1111/dom.15461","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.15461","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15461","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:38413384","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38413384","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/dom.15461","doi":"https://doi.org/10.1111/dom.15461","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.15461","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15461","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G7059588002","display_name":"Glycan abnormalities and progression of diabetic kidney disease","funder_award_id":"23K24349","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320327566","display_name":"Mitsubishi Tanabe Pharma Corporation","ror":"https://ror.org/038ehsm73"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4392235441.pdf","grobid_xml":"https://content.openalex.org/works/W4392235441.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W2153390494","https://openalex.org/W2159760627","https://openalex.org/W2492672367","https://openalex.org/W2512638651","https://openalex.org/W2774743973","https://openalex.org/W2787269887","https://openalex.org/W2939222610","https://openalex.org/W2970412630","https://openalex.org/W2996130540","https://openalex.org/W3003968696","https://openalex.org/W3005957464","https://openalex.org/W3087450863","https://openalex.org/W3087681641","https://openalex.org/W3088173406","https://openalex.org/W3103002140","https://openalex.org/W3112498330","https://openalex.org/W3154796681","https://openalex.org/W3159078474","https://openalex.org/W3173377533","https://openalex.org/W3202796626","https://openalex.org/W4221134792","https://openalex.org/W4282939740","https://openalex.org/W4308183941","https://openalex.org/W4308291843","https://openalex.org/W6748242114"],"related_works":["https://openalex.org/W3003968696","https://openalex.org/W2894854793","https://openalex.org/W4386710353","https://openalex.org/W4404983066","https://openalex.org/W4405915395","https://openalex.org/W4386768291","https://openalex.org/W3150612515","https://openalex.org/W7169781184","https://openalex.org/W4396997098","https://openalex.org/W4398251971"],"abstract_inverted_index":{"Abstract":[0],"Aim":[1],"To":[2],"evaluate":[3],"whether":[4],"sodium\u2010glucose":[5],"cotransporter":[6],"2":[7,30,97],"inhibitor":[8],"(SGLT2i)":[9],"therapy":[10],"is":[11],"associated":[12],"with":[13,20,28,51,233],"a":[14,42,132,142,242],"reduction":[15],"of":[16,71,134,137,147,245],"renal":[17,246],"events":[18,247],"compared":[19],"other":[21],"glucose\u2010lowering":[22],"drugs":[23,73],"(oGLDs)":[24],"among":[25],"Japanese":[26,231],"people":[27,232,249],"type":[29],"diabetes":[31],"(T2D)":[32],"and":[33,48,82,108,115,172,216,235],"grade":[34],"3":[35],"(G3)":[36],"chronic":[37],"kidney":[38,139],"disease":[39,140],"(CKD)":[40],"in":[41,145,169,178,183,192,197,201,217],"real\u2010world":[43],"clinical":[44],"practice":[45],"setting.":[46],"Materials":[47],"Methods":[49],"People":[50],"T2D":[52,234],"who":[53],"were":[54,99,118,154,181],"newly":[55],"prescribed":[56],"an":[57,60,239,251],"SGLT2i":[58,114,194,240],"or":[59,141,149],"oGLD":[61,116,199],"from":[62,101],"April":[63],"2014":[64],"to":[65,79,92,211,225],"November":[66],"2021":[67],"(without":[68],"prior":[69,78],"use":[70],"index":[72,80],"for":[74],"\u2265":[75,90],"1":[76],"year":[77],"date)":[81],"G3":[83,236],"CKD":[84,237],"(estimated":[85],"glomerular":[86],"filtration":[87],"rate":[88],"[eGFR]":[89],"30":[91],"<":[93,214],"60":[94],"mL/min/1.73":[95],"m":[96],")":[98],"selected":[100],"the":[102,109,135,157,170,179,184,193,198,202,218],"Medical":[103],"Data":[104,111],"Vision":[105],"database":[106,112],"(MDV\u2010DB)":[107],"Real\u2010World":[110],"(RWD\u2010DB).":[113],"users":[117],"matched":[119],"(1:1)":[120],"using":[121,156],"propensity":[122],"score":[123],"on":[124],"patient":[125],"background":[126],"characteristics.":[127],"The":[128,186],"primary":[129],"endpoint":[130],"was":[131,189],"composite":[133,187],"development":[136],"end\u2010stage":[138],"sustained":[143],"decline":[144],"eGFR":[146],"50%":[148],"more.":[150],"Hazard":[151],"ratios":[152],"(HRs)":[153],"estimated":[155],"Cox":[158],"proportional":[159],"hazards":[160],"model.":[161],"Results":[162],"Overall,":[163],"3190":[164],"(1595":[165],"per":[166,175],"group)":[167,176],"patients":[168,177],"MDV\u2010DB":[171,203],"2572":[173],"(1286":[174],"RWD\u2010DB":[180,219],"included":[182],"analyses.":[185],"outcome":[188],"significantly":[190],"lower":[191,243],"group":[195,200],"than":[196,248],"(HR":[204,220],"0.49,":[205],"95%":[206,222],"confidence":[207],"interval":[208],"[CI]":[209],"0.33":[210],"0.74,":[212],"P":[213,227],"0.001)":[215],"0.57,":[221],"CI":[223],"0.37":[224],"0.88,":[226],"=":[228],"0.011).":[229],"Conclusions":[230],"initiating":[238,250],"had":[241],"risk":[244],"oGLD.":[252]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2024-03-05T00:00:00"}